ArticleJournal of nanobiotechnology2026
Targeted delivery of TGF-β inhibitor via LHRH-NanoTi reverses the NAT10/ac4C-mediated cisplatin-induced immunosuppressive tumor microenvironment in ovarian cancer.
Fei Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.